期刊文献+

乳腺亲肿瘤显像使用模型的改进 被引量:1

Improvement of Breast Tumor Imaging Device
下载PDF
导出
摘要 目的:改进乳腺亲肿瘤显像的模型。方法:选择乳腺肿瘤患者进行原模型及改进后模型的亲肿瘤显像。结果:改进后模型和原模型在同一部位感兴趣区与原模型双乳中间的散射光团上方的1/3中心位置的感兴趣区相比有非常明显的差异。结论:改进后的乳腺亲肿瘤显像模型无散射现象,图像清晰。 Objective To improve the breast tumor imaging device.Methods The original device and the improved device were used for the breast imaging in patients with breast cancer.Results There were obvious differences between the region of interest(ROI) in the image of the improved and original device in the same part and at the top 1/3 center position of the scattering light in the middle of breasts.Conclusion The improved breast tumor imaging device is without scattering phenomenon,and the image is clear.[Chinese Medical Equipment Journal,2012,33(6):69,84]
出处 《医疗卫生装备》 CAS 2012年第6期69-69,84,共2页 Chinese Medical Equipment Journal
关键词 乳腺癌 乳腺亲肿瘤显像 感兴趣区 断层显像 breast neoplasm breast tumor imaging ROI tomography imaging
  • 相关文献

参考文献5

  • 1Isabelle M, Stephane M, Bernard W ,et al. Inconclusive triple diag- nosis in breast cancer imaging: is there a place for scintimammogra- phy[J]. J Nucl Med,2005,46:1 574-1 581.
  • 2Wilczek B,Aspelin P,Bone B,et ol. Complementary use of scinti- mammography with 99mTc-MIB to triple diagnostic procedure in palpable and non-palpable breast lesions[J]. Acta Radiol, 2003,44: 288-293.
  • 3Taillefe R. Clinical applications of 99mTc-sestamibi scintimammog- raphy[J]. Seminars im Nuclear Medicine ,2005,35 : 100-115.
  • 4张雪梅,张振蔚,吴华.乳腺肿瘤摄取^(99)Tc^m-甲氧基异丁基异睛与耐多药蛋白表达的关系[J].中华肿瘤杂志,2004,26(6):353-355. 被引量:14
  • 5刘金华,欧阳伟,冯会娟,胡瑞,刘伟英,黄柳华.Infinia Hawkeye CT球管维护[J].医疗卫生装备,2010,31(10):120-121. 被引量:7

二级参考文献13

  • 1卢健,胡志忠,杨如乃.医学图像融合技术的研究[J].上海生物医学工程,2006,27(3):163-167. 被引量:14
  • 2O'connor M K,Kemp B T.single-photon emission computer tomography/computed tomography:basie instrumentation and innovations[J].Semin nucl Med,2006,36:258-266.
  • 3Nomayr A,Rower W,Strobel D,et al.Anatomical accuracy of hybrid SPECT/spiral CT in the lower spine[J].Nuel Med commiun,2006,36:521-528.
  • 4Biedler JL, Riehm H. Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies. Cancer Res, 1970,30:1174-1184.
  • 5Vecchio SD, Ciarmiello A, Potena MI, et al. In vivo detection of multidrug-resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients. Eur J Nucl Med, 1997,24:150-159.
  • 6Moretti JL, Duran Cordobes M, Starzec A, et al. Involvement of glutathione in loss of technetium-99m-MIBI accumulation related to membrane MDR protein expression in tumor cells. J Nucl Med, 1998,39:1214-1218.
  • 7Zhou J, Higashi K, Ueda Y, et al. Expression of multidrug resistance protein and messenger RNA correlate with (99m) Tc-MIBI imaging in patients with lung cancer.J Nucl Med, 2001,42:1476-1483.
  • 8Petrini M, Di Simone D, Favati A, et al. GST-pi and P-170 co-expression in multiple myeloma. Br J Haematol, 1995,90:393-397.
  • 9Luker GD, Fracasso PM, Dobkin J, et al. Modulation of the multidrug resistance P-glycoprotein: detection with technetium-99m-sestamibi in vivo. J Nucl Med, 1997, 38:369-372.
  • 10Schomacker K, Schicha H. Use of myocardial imaging agents for tumour diagnosis:a success story? Eur J Nucl Med, 2000, 27:1845-1863.

共引文献19

同被引文献18

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部